Gigamune

Developing in vivo cell therapies for cancer and inherited blood disorders

placeSan Francisco, California, United States calendar_todayFounded 2017 groups3 employees language gigamune.com

Registered entities

Innovation

6 patent families (3 granted) — focus: Chemistry & metallurgy; filing pace steady. Cited 748 times.

YearFilings
20181
20202
20223
20233
20243
20253

Investor mix

2 investors on record.

Investor typeCountShare
Venture capital150%
Other / undisclosed150%
Coming soon